KRAS and colorectal carcinoma: Supporting our work, increased secretion of the high-affinity EGFR ligands TGF-α and BTC by some KRAS-mutant clones has been suggested to be a paracrine resistance mechanism to anti-EGFR antibodies in CRC models [47,48,49].